Floatz logo

FIALURIDINE

Kaposi's Sarcoma

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Kaposi's Sarcoma cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

FIALURIDINE is also rated in:

Non Hodgkin LymphomaDormant
D
Indicative ·
30 / 100
View asset →
Nasopharyngeal CancerDormant
D
Indicative ·
30 / 100
View asset →
Hodgkin LymphomaDormant
D
Indicative ·
28 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →